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Objective. To compare the performances of Papanicolaou test (PapTest) and of a new liquid-based cytology method, DNA-CitoliqR
System (DCS), in a high-risk population, with histology confirmation.
Methods. Paired specimens of exfoliated cervical cells were collected under split-sample protocol. All patients were submitted to
colposcopy and a biopsy taken when any atypical transformation zone was seen. Sensitivity, specificity, positive and negative predictive
values, and overall accuracy of both conventional and DCS methods were computed in relation to histology.
Results. A total of 1095 patients were analyzed by two cytology methods and, in 425 (38.8%), histologically. There were
significantly more adequate samples with DCS (98.63%) than with conventional (89.6%) smears (P b 0.001). ASCUS was diagnosed
significantly more with DCS than with conventional Pap (P b 0.001). Conventional Pap misclassified as normal 55.4% (158/285) of
cases with either LSIL or HSIL or cancer at histology, whereas DCS misclassified 31.2% (89/285) of cases (P b 0.001). DCS had a
significantly higher sensitivity (70% and 91.3%) than the conventional Pap (49.8% and 72.8%) to detect both LSIL+ and HSIL+ at
histology, respectively. On the other hand, specificity of conventional smear (88.2% and 85.2%) was significantly higher than DCS
(75.4% and 70.9%) considering both LSIL+ and HSIL+ at histology, respectively.
Conclusions. This study confirms the superiority of the liquid-based cytology system DCS to detect cervical lesions. The rate of adequate
DSC slides was significantly higher than with conventional cytology.
D 2005 Elsevier Inc. All rights reserved.
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diagnosis was made possible with the development of a liquid
medium that allows preservation of cell morphology for
cytopathological evaluation and nucleic acids for molecular
tests [1,2]. One such medium, the Universal Collection
Medium (UCM) [DNA-CitoliqR System (DCS)], an alcohol-
based fixative, has been recently developed and tested
clinically [3,4]. The performance of this medium in preserv-
ing cell morphology was well documented in a recent study97 (2005) 497–500
A. Longatto Filho et al. / Gynecologic Oncology 97 (2005) 497–500498[5] such as its capacity to preserve samples for biomolecular
investigation.
The apparent laboratorial simplicity of Pap smear
actually involves different steps of a complex procedure.
To produce a cervical sample with adequate squamous
columnar cells representation requires skills in patient
preparation, specimen collection, laboratory processing,
and slide interpretation [6]. Despite adequate care in
preparing the conventional smear, only about 20% of cells
are effectively transferred to the slide [7]. In contrast, the
liquid-based cytology provides clear background without
cellular overlapping and the analyses can be more expedi-
tious than the conventional smear [8]. In addition, in the
liquid-based procedure, the cells ultimately transferred to
the slide are likely to be more representative of the overall
sample to be screened. All factors considered, liquid-based
cytology has demonstrated higher sensitivity to detect
cervical lesions than conventional smears [9–14].
Indeed, the clinical significance of an abnormal cytology
can only be assessed by comparing cytology results with
histology of biopsy specimens. It should be pointed out,
however, that women with low grade lesions (LSIL) and
ASCUS detected in liquid-based cytology are often not
referred to colposcopy and therefore, do not undergo
cervical biopsy [11]. Moreover, as most studies have
generally included women from the general population,
high grade lesions (HSIL) and cancers have usually been
underrepresented [11,12]. There is a scarcity of data
comparing the accuracy of liquid-based cytology with
histological diagnosis in high-risk populations [13].
The goal of this investigation was to compare, in a split-
sample protocol, the screening performance of conventional
smears with the new liquid-based cytology method, DCS, in
a high-risk population, using colposcopy followed by
histology as bgold standard.QMaterials and methods
After approval of the Institutional Review Board of both
institutions involved in the project, 1095 consecutive
women were prospectively enrolled in the study. All tests
were performed in blind fashion protocol.
Our study focused on high-risk population defined as
women presenting with any aceto-white positive lesion
detected on speculum visual inspection, abnormal cytology,
and/or previous history of cervical lesion. These women
were referred to Pe´rola Biygnton Hospital, a public
reference center for women genital diseases in Sa˜o Paulo
city, Brazil, where the study was carried out.
In all cases, cytological samples were collected in a split-
sample protocol. Conventional samples, collected with
Ayre’s spatula and endocervical brush, were smeared into
the slide and immediately fixed with polyethylene glycol.
The same brush was again used for brushing the ectocervix
and placed into tubes containing 1 ml of UCMR. Thepurpose was to prioritize for conventional smears the best
conditions for the cytological investigation, and for liquid-
based samples, the remaining material. Following collection
of cervical specimens, all 1095 women have undergone
colposcopy and guided biopsy, when applicable. Conization
or hysterectomy was also taken into account, if available, in
final histologic diagnosis. The samples for cytology and
histology evaluation were processed at Pathology Division
of Adolfo Lutz Institute, a reference laboratory in Sa˜o Paulo.
Once at the laboratory, batches of 12 DCS samples were
simultaneously prepared in 10 to 15 min. In DCS system,
the specimen in the slide is contained in a 25-mm-diameter
circle. Both conventional and DCS slides were stained
according to the Papanicolaou method and classified
according to Bethesda 2000 System [15]. Professionals
trained in the evaluation of thin-layer slides manually
screened all slides. The pair of DCS and conventional
slides of each patient were examined by the same cytologist
blinded to the result of its pair. All positive and suspicious
cases were reviewed and forwarded to the senior cytopa-
thologist for final diagnosis, also blinded to the result of the
other slide preparation method and histological diagnosis.
Histological specimens were initially evaluated according to
WHO classification of squamous lesions in three classes
(CIN 1, 2, and 3) [16], blinded to cytological results.
However, for comparing with cytological diagnoses, two
categories were adopted: LSIL and HSIL.
For the purpose of statistical analysis, squamous and
glandular atypical findings of undetermined significance
were grouped in one category; three different cutoffs of a
positive cytology were used: ASCUS+, LSIL+, and HSIL+;
two cutoffs of a positive histology were used: presence of
any lesion and HSIL/cancer; histology was considered the
gold standard. Women with no abnormality at the colpo-
scopy were recorded as negative histology.
Sensitivity, specificity, positive and negative predictive
values, and overall accuracy of both conventional and DCL
methods were computed in relation to histology. Using
Pearson’s v2 test, differences in sensitivity and specificity of
the two cytologic methods were compared. A difference was
statistically significant if the P value was V0.05. Data were
stored as excel files and analyzed using the SPSS statistical
software, version 10.Results
The mean age was 34.7 years (14 to 86). There were
significantly more adequate samples with DCS (98.63%)
than with conventional (89.6%) smears (P b 0.001). The
main causes for conventional slide inadequacy were
sample obscured by red blood cells followed by dense
inflammatory infiltrate. For the DSC slides, the main cause
was the presence of massive red blood cells. The screening
prevalence of ASCUS and squamous intraepithelial lesions
according to DCS and conventional Pap are listed in
Table 1
Cytology results (DCS) compared to colposcopy followed by histology
findings (bgold standardQ)
Cytology results Histologic results Total
Normal LSIL HSIL Cancer
Unsatisfactory 10 4 1 0 15
Normal 603 73 11 0 687
ASCUS/AGC 102 22 25 2 151
LSIL 61 42 29 0 132
HSIL 34 17 52 4 107
Cancer 0 0 2 1 3
Total 810 158 120 7 1095
Table 3
Sensitivity, specificity, positive (+PV) and negative (PN) predictive
values, and overall accuracy of DCS and conventional Pap for any
histological alterations (LSIL+)
DCSR Conventional P value
Sensitivity 70.00% 49.80% b0.0001
Specificity 75.38% 88.22% b0.0001
+ PV 49.87% 59.24% 0.037
 PV 87.77% 83.64% 0.032
Accuracy 73.98% 78.39% 0.023
Sensitivity: positive cytology results / total positive histologic results.
Specificity: negative cytology results / total negative histologic results.
PV = predictive value.
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with DCS than with conventional Pap smear (P b 0.001).
However, out of the 99 cases of ASCUS with DCS and
normal with conventional Pap smear, there were 13 cases
of HSIL and 17 cases of LSIL in histology. Overall, the
conventional Pap smear misclassified as normal 55.4%
(158/285) of cases with either LSIL or HSIL or cancer at
histology, whereas DCS misclassified 31.2% (89/285) of
cases (P b 0.001). Tables 3 and 4 summarize the
diagnostic parameters of conventional and DCS prepara-
tions. DCS had a significantly higher sensitivity (70% and
91.3%) than the conventional Pap smear (49.8% and
72.8%) to detect both LSIL+ and HSIL+ at histology,
respectively. On the other hand, specificity of conventional
smear (88.2% and 85.2%) was significantly higher than
DCS (75.4% and 70.9%) considering both LSIL+ and
HSIL+ at histology, respectively.Discussion
Although, ideally, a screening test for cervical lesions
should have both perfect sensitivity and specificity, such test
is not available. Therefore, the screening tool ought to
prioritize sensitivity, so that no lesion would escape
detection at the expense of a somewhat diminished
specificity. Any positive result at screening, including
ASCUS, simply means that further investigation is required
to confirm the diagnosis. This study confirms the superiority
of the liquid-based cytology system DCS as a screening test
to detect cervical lesions. The rate of adequate DSC slidesTable 2
Cytology results (conventional) compared to colposcopy followed by
histology findings (bgold standardQ)
Cytology results Histologic results Total
Normal LSIL HSIL Cancer
Unsatisfactory 80 21 12 1 114
Normal 644 95 30 1 770
ASCUS/AGUS 42 15 10 1 68
LSIL 29 22 25 0 76
HSIL 15 5 40 3 63
Cancer 0 0 3 1 4
Total 810 158 120 7 1095was significantly higher than with conventional cytology.
Furthermore, DSC proved to be more sensitive than
conventional smears to detect both histologically proved
LSIL and HSIL in this high-risk population. Out of the 1095
patients enrolled in this study, 285 (26%) had LSIL, HSIL,
or cancer at histology.
A screening test, as opposed to a diagnostic procedure,
should have a low threshold to detect disease, i.e., should
have high sensitivity. A case screened positive warrants
further diagnostic investigation to confirm or rule out
disease. Cervical cytology is no exception. Conventional
cytology has long been known for its low sensitivity,
attributed to inadequate sample collection and interpretation
difficulties [17]. Higher sensitivity of liquid-based cytology
has been well documented [18–21]. DSC, a novel liquid-
based system, has similar cell morphology as ThinPrep and
Autocyte [5]. As per this study protocol, DSC slides used
residual cells. Despite favoring the conventional method,
DSC proved to be a superior screening test, as demonstrated
by its much higher sensitivity and positive predictive value
to detect both LSIL and HSIL at histology. A direct-to-vial
protocol could yield even better results, as reported by
Vassilakos et al. [12]. DSC has been previously compared to
the conventional method using a similar sample collection
protocol, but with no histological confirmation [22].
Recently, Pan et al. [13], using ThinPrep methodology and
colposcopy followed by biopsy when applicable, studied
1997 women in a high incidence area of cervical cancer in
China. All 12 squamous cell carcinoma and 87% of the HSIL
at histology were detected by that liquid-based cytology.
Abufala et al. [14], also using ThinPrep, have showed a
sensitivity of 76% with ThinPrep versus 68% with conven-Table 4
Sensitivity, specificity, positive (+PV) and negative (PN) predictive
values, and overall accuracy of DCS and conventional Pap for HSIL+ at
histology
DCSR Conventional P value
Sensitivity 91.27% 72.81% b0.0001
Specificity 70.86% 85.24% b0.0001
+ PV 29.26% 39.34% 0.017
 PV 98.40% 95.97% 0.009
Accuracy 73.24% 83.79% b0.0001
PV = Predictive value.
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However, Chacho et al. [23] did not find the ThinPrep system
to be any more effective than conventional smears to detect
invasive carcinomas or intraepithelial lesions.
Although DSC falls short from being an ideal screening
test for cervical lesions, as it misses 31.2% of histologically
confirmed lesions, it performs significantly better than
conventional cytology which misses 55.4% of lesions.
Considering only satisfactory samples, DSC missed only
4% of HSIL at histology, as compared to 10% with conven-
tional cytology, the remaining being ASCUS or LSIL.
Among the 687 cases with negative DSC results, 10.6%
and 1.6% were LSIL and HSIL at histology, respectively.
Similarly, among the 770 cases with negative results with the
conventional cytology, 12.3% and 4% were LSIL and HSIL,
respectively. In both situations, a false-negative colposcopy is
the likely explanation for such discrepancies. Other studies
have pointed out less than ideal diagnostic reproducibility
with cytology and histology [24,25]. Possible reasons to
explain this poor inter-observer agreement remain to be
elucidated. However, quality assurance procedures in each
step could minimize the errors, as advocated by Petry et al.
[26], although such procedures are difficult to implement in
routine care.
In conclusion, DCS, a screening method that can be easily
implemented in clinical practice, is associated with fewer
unsatisfactory samples and a significantly higher sensitivity
when compared to conventional cytology. In addition, DCS
has the advantage of collecting material for HPV-DNA
Hybrid capture test, when deemed necessary.Acknowledgments
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